Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Peptides. 2010 Aug 17;31(11):2075–2082. doi: 10.1016/j.peptides.2010.07.023

Table 1.

Arterial systolic, diastolic, and mean arterial pressures (MAP) and Heart Rate from control and experimental groups. UTII − 4 week administration of urotensin II; VO − 4 week volume overload; VO+UTII − 4 week VO + 4 week UTII administration (Data are reported as mean ± sem with n = 8 in all groups)

Groups Systolic
(mmHg)
Diastolic
(mmHg)
MAP
(mmHg)
Heart Rate
(Beats/minute)
Control 117.6 ± 4.5 70.3 ± 8.3 86.1 ± 6.6 314 ± 25
UTII 103.6 ± 6.7* 83.0 ± 6.7 89.9 ± 6.5$ 335 ± 14
VO 83.5 ± 3.4*# 56.2 ± 8.3 65.3 ± 6.6* 326 ± 16
VO+UTII 100.0 ± 3.1* 62.0 ± 1.3 74.7 ± 1.5 341 ± 21
*

p<0.05 vs. Control

p<0.05 vs. VO+UTII

#

p<0.05 vs. UTII

$

p<0.05 vs. VO